Uxin Raises US$25 Million in Two Private Placements
BEIJING, Oct. 06, 2020 (GLOBE NEWSWIRE) — Uxin Limited (“Uxin” or the “Company”) (Nasdaq: UXIN), a leading national online used […]
AbCheck s.r.o. Receives Grant to Further Develop a Discovery Technology for Functional Antibodies using Microfluidics
Pilsen, Czech Republic, October 6, 2020 – AbCheck s.r.o., a leader in providing antibody drug discovery, engineering and optimization services […]
Eagle Bancorp Announces Earnings Call On October 22, 2020
BETHESDA, Md., Oct. 06, 2020 (GLOBE NEWSWIRE) — Eagle Bancorp, Inc., (the “Company”) (NASDAQ: EGBN), the parent company of EagleBank, […]
Radware Announces 2020 Annual General Meeting
TEL AVIV, Israel, Oct. 06, 2020 (GLOBE NEWSWIRE) — Radware® (NASDAQ: RDWR), a leading provider of cyber security and application […]
Amphastar Pharmaceuticals Receives FDA Approval for Atropine Sulfate Injection
RANCHO CUCAMONGA, Calif., Oct. 06, 2020 (GLOBE NEWSWIRE) — Amphastar Pharmaceuticals, Inc. (NASDAQ: AMPH) announced that the U.S. Food and […]
Mimecast Recognized as a Cybersecurity Awareness Month Champion
LEXINGTON, Mass., Oct. 06, 2020 (GLOBE NEWSWIRE) — Mimecast Limited (NASDAQ: MIME), a leading email security and cyber resilience company, today announced […]
Himax Technologies, Inc. Pre-announces Preliminary Unaudited Third Quarter 2020 Financial Results
TAINAN, Taiwan, Oct. 06, 2020 (GLOBE NEWSWIRE) — Himax Technologies, Inc. (Nasdaq: HIMX) (“Himax” or “Company”), a leading supplier and […]
BioNTech and Pfizer Initiate Rolling Submission to European Medicines Agency for SARS-CoV-2 Vaccine Candidate BNT162b2
Rolling review accepted by the EMA based on available preclinical and clinical data for BNT162b2 to dateBioNTech and Pfizer will […]
argenx Expands Capabilities In Antibody Engineering Through Key Technology Partnerships
New partnerships with Chugai and the Clayton Foundation for Research provide access to innovative antibody engineering technologies Extension of Halozyme collaboration […]
AMAG Pharmaceuticals Provides Update on FDA’s Proposal Regarding Makena® (Hydroxyprogesterone Caproate Injection)
The product remains on the marketAMAG has 15 days to respond to the FDAAMAG continues to expect its recently announced […]
